MusclePharm is a scientifically driven, performance lifestyle Company that currently develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a complete range of powders, capsules, gels, bars, and drinks. Its portfolio of recognized brands, including MusclePharm Hybrid,Core Series, and FitMiss. These clinically proven, scientific nutritional supplements are developed through a six-stage research process that utilizes the expertise of leading nutritional scientists, doctors and universities. 
Type
Public
HQ
Denver, US
Founded
2008
Size (employees)
74 (est)
MusclePharm was founded in 2008 and is headquartered in Denver, US
Report incorrect company information

MusclePharm Office Locations

MusclePharm has an office in Denver
Denver, US (HQ)
4721 Ironton Street
Denver, US
3200 Cherry Creek S Dr
Show all (2)
Report incorrect company information

MusclePharm Financials and Metrics

MusclePharm Revenue

MusclePharm's revenue was reported to be $132.50 m in FY, 2016 which is a 20.6% decrease from the previous period.
USD

Revenue (Q2, 2018)

53.7 m

Gross profit (Q2, 2018)

16.4 m

Gross profit margin (Q2, 2018), %

30.5%

Net income (Q2, 2018)

(3.4 m)

Cash (30-Jun-2018)

2.4 m

EV

15.2 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

177.4 m166.9 m132.5 m

Revenue growth, %

(6%)(21%)

Cost of goods sold

77.7 m121.4 m109.9 m88 m

Gross profit

56 m56.9 m44.5 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

41.3 m50.5 m34 m42.9 m32.9 m30.7 m26 m24.4 m26.5 m53.7 m

Cost of goods sold

31.1 m32.8 m26.9 m33 m23.5 m27.7 m22.2 m20.5 m19.5 m16.4 m18.3 m37.3 m

Gross profit

14.4 m17.5 m10.5 m15.2 m10.7 m10.2 m6.5 m8 m8.2 m16.4 m

Gross profit Margin, %

35%35%31%35%33%33%25%33%31%31%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

5.4 m1 m7.1 m4.9 m

Inventories

15.8 m1.7 m3.7 m8.6 m

Current Assets

44.5 m46.4 m47.3 m28.8 m

PP&E

7.8 m6.7 m3.2 m
Quarterly
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

3.8 m2.9 m4.2 m3.5 m9.1 m13.1 m5.9 m3 m4.9 m5.1 m2.4 m

Accounts Receivable

1.3 m

Inventories

24 m14.9 m19.3 m8.6 m6.9 m8 m6.1 m6.3 m7.7 m7.7 m

Current Assets

50.5 m59 m53.2 m45.2 m45.2 m44.8 m32.9 m26.6 m26.3 m30.8 m27.5 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(17.7 m)(13.8 m)(51.9 m)(3.5 m)

Depreciation and Amortization

709 k1.3 m1.8 m1.6 m

Inventories

2 k(2.2 m)(480 k)

Accounts Payable

14.2 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

3.1 m2.4 m(7.5 m)(14.5 m)(42.2 m)(6.6 m)(4.2 m)(1.4 m)(3.1 m)(2.3 m)(3.4 m)

Depreciation and Amortization

646.7 k382 k838 k1.3 m427 k420 k287 k558 k

Inventories

(3.2 m)(7.4 m)7.2 m6.2 m487 k2.3 m6.9 m8 m2.5 m1.9 m(1.3 m)(1.2 m)

Accounts Payable

(2.7 m)2 m719 k10.1 m(14.9 m)(591 k)39.1 m36.1 m9.4 m2.9 m5.8 m
USDY, 2018

EV/CFO

-389.7 x

Financial Leverage

-1.9 x
Show all financial metrics
Report incorrect company information

MusclePharm Online and Social Media Presence

Embed Graph
Report incorrect company information

MusclePharm News and Updates

Report incorrect company information

MusclePharm Company Life and Culture

Report incorrect company information